PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Actinium Pharmaceuticals, Inc. (ATNM)
1.780.01 (-0.56%)
1.75 - 1.81
1.03 - 2.41
122.5K / 297.6K (Avg.)
-1.36 | -1.31
Identifies how quickly the company is scaling its balance sheet (via acquisitions, expansions, or debt). Strong growth, accompanied by sound fundamentals, can support long-term intrinsic value—while disproportionate debt expansion or bloated intangible assets can signal elevated risk.
-16.72%
Cash & equivalents declining signals potential liquidity drain. Benjamin Graham would investigate if this is from strategic investments or operational shortfalls.
No Data
No Data available this quarter, please select a different quarter.
-16.72%
Declining total liquid assets may signal capital redeployment or liquidity concerns. Howard Marks would investigate the underlying causes.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-100.00%
Declining other current assets simplifies the balance sheet. Howard Marks would confirm no essential assets are being eliminated.
-19.08%
Declining current assets may signal efficient working capital or liquidity concerns. Benjamin Graham would investigate the composition of the decline.
-14.24%
Declining PP&E may indicate underinvestment or asset sales. Seth Klarman would question future capacity constraints.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-9.11%
Declining non-current assets may signal asset sales or underinvestment. Howard Marks would investigate future growth implications.
No Data
No Data available this quarter, please select a different quarter.
-19.02%
Declining total assets may signal asset sales or strategic downsizing. Seth Klarman would investigate the strategic rationale.
-4.20%
Declining payables indicates faster supplier payments but reduces free financing. Howard Marks would verify liquidity remains adequate.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
76.87%
Above 5% yoy – potential spike in near-term liabilities. Philip Fisher demands details on these obligations.
18.79%
Above 15% yoy – a notable jump. Philip Fisher demands clarity on how short-term liabilities are managed.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
18.79%
Above 10% yoy – large jump. Philip Fisher demands clarity on whether growth justifies the leverage.
2.42%
Up to 5% yoy – small issuance. Howard Marks asks if new capital is used productively.
-5.90%
Declining retained earnings signals net losses or large dividends. Seth Klarman would investigate the sustainability of dividend policy.
-12.27%
Declining AOCI may indicate reduced unrealized gains or currency losses. Howard Marks would see this as potentially reducing volatility.
No Data
No Data available this quarter, please select a different quarter.
-28.51%
Declining stockholders equity may signal losses or large distributions. Seth Klarman would investigate the underlying causes and sustainability.
-19.02%
Declining total capital may indicate asset sales or poor capital allocation. Howard Marks would investigate strategic implications.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
16.72%
Above 5% yoy – net debt expansion. Philip Fisher demands clarity on the reason for higher leverage vs. cash.